Novel Coronavirus (SARS-CoV-2/COVID-19)
The COVID-19 pandemic continues to place unprecedented demands on America鈥檚 health care system. The recent sharp increase in the number of patients needing acute hospital care means that some hospitals could face more significant shortages of staff and medical supplies such as personal protective鈥
The Centers for Disease Control and Prevention allocated $22 billion in funding to states, localities and territories for COVID-19 testing and vaccination activities authorized in December by the Coronavirus Response and Relief Supplemental Appropriations Act.
The Centers for Medicare & Medicaid Services released updated guidance in response to questions on maintaining Medicaid enrollment during the Public Health Emergency under its interim final rule implementing Section 6008 of the Families First Coronavirus Response Act.
The AHA released the latest edition of the COVID-19 Snapshot, which highlights the critical needs of hospitals and health systems during the deepening public health emergency.
Department of Health and Human Services Secretary Alex Azar, Jan. 8 at 1 p.m. ET will discuss public health initiatives that HHS has worked on over the past four years, as well as activities related to the COVID-19 pandemic, including vaccination efforts.
The AHA urged the Department of Health and Human Services to take certain steps to speed COVID-19 vaccinations.
The past 10 months have been filled with jarring and dissonant images, scenes that have prompted us to say, 鈥渘ever thought we鈥檇 see that in our country.鈥 Unfortunately, we now have to add yesterday鈥檚 storming of the U.S. Capitol and assault on our democracy to that mix.
The Federal Bureau of Investigation and the Cybersecurity and Infrastructure Security Agency have observed鈥攕ince the summer of 2020鈥攁 surge of DoppelPaymer ransomware attacks against emergency services and healthcare entities. This activity has negatively impacted the provision of critical services鈥
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.
The Centers for Disease Control and Prevention reported 21 cases of anaphylaxis, a life-threatening allergic reaction, among the nearly 1.9 million people who received a first dose of the Pfizer COVID-19 vaccine between Dec. 14 and 23.